Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [391]

Novel drug targets and potential combinations in childhood brain tumours

Dr Stefan Pfister - German Cancer Research Center (DKFZ), Heidelberg, Germany

Novel drug targets and potential combinations in childhood brain tumours ( Dr Stefan Pfister - German Cancer Research Center (DKFZ), Heidelberg, Germany )

Eltrombopag helped reduce bleeding in children with immune thrombocytopenic...

Dr John Grainger - Royal Manchester Children's Hospital, Manchester, UK

Eltrombopag helped reduce bleeding in children with immune thrombocytopenic purpura ( Dr John Grainger - Royal Manchester Children's Hospital, Manchester, UK )

Eltrombopag helped reduce bleeding in children with immune thrombocytopenic...

Dr John Grainger - Royal Manchester Children's Hospital, Manchester, UK

Eltrombopag helped reduce bleeding in children with immune thrombocytopenic purpura ( Dr John Grainger - Royal Manchester Children's Hospital, Manchester, UK )

Role of AORTIC in dealing with rising cancer rates in Africa

North American Vice president of AORTIC

Role of AORTIC in dealing with rising cancer rates in Africa ( North American Vice president of AORTIC )

The global control and prevention of cervical cancer caused by HPV

Prof Thomas Broker - University of Alabama, Birmingham, USA

The global control and prevention of cervical cancer caused by HPV ( Prof Thomas Broker - University of Alabama, Birmingham, USA )

ecancermedicalscience Editor's Choice for January 2014

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

ecancermedicalscience Editor's Choice for January 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )

Gemtuzumab improves event free survival for paediatric acute myeloid leukaemia...

Dr Alan Gamis - University of Missouri-Kansas City School of Medicine, USA

Gemtuzumab improves event free survival for paediatric acute myeloid leukaemia (AML) ( Dr Alan Gamis - University of Missouri-Kansas City School of Medicine, USA )

Treating ALL patients with T cells targeted for CD19

Dr Laurence Cooper - MD Anderson Cancer Center, Houston, USA

Treating ALL patients with T cells targeted for CD19 ( Dr Laurence Cooper - MD Anderson Cancer Center, Houston, USA )

Chimeric antigen receptor produces complete responses and long-term persistence...

Dr. Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA

$Chimeric antigen receptor produces complete responses and long-term persistence in children and adults relapsed, refractory ALL ( Dr. Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA )$

Long-term functional persistence, B cell aplasia and anti-leukaemia efficacy in...

Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA

$Long-term functional persistence, B cell aplasia and anti-leukaemia efficacy in refractory B cell malignancies ( Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA )$

T cells engineered with chimeric antigen receptor targeting CD19 produce...

Dr Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA

T cells engineered with chimeric antigen receptor targeting CD19 produce significant long-term persistence ( Dr Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA )

Removal of alpha/beta T cells and of CD19 B cells in children With acute...

Dr Alice Bertaina - IRCCS Bambino Gesù Children's Hospital, Rome, Italy

Removal of alpha/beta T cells and of CD19 B cells in children With acute leukaemia ( Dr Alice Bertaina - IRCCS Bambino Gesù Children's Hospital, Rome, Italy )

More from ecancer